# Sonida Senior Living, Inc. (SNDA)

> Source: Nexqual · https://nexqual.com/SNDA · data as of 2026-10-22 20:00 UTC · cite as "Nexqual, Sonida Senior Living, Inc. (SNDA), nexqual.com/SNDA" · informational, not investment advice.

**Price:** USD 33.87 (+1.20% on the day) · last close of Oct 22, 2026; US market pre market, not a live price. Prev close 33.47 · day 33.12–34.05 · 52w 24.95–44.39 · market cap $1.63B · NYQ

## Key facts
- Last four reported quarters (through Jun 30, 2026): revenue $526M, net income -$122M (-23.3% margin), free cash flow -$52.7M (SEC filings).
- 1 of 80 tracked superinvestors hold SNDA (13F, Q2 2026): 1 new, 0 added, 0 reduced, 0 unchanged.
- Insider open-market sales, last ~7 months: 4 Form 4 filings, $11.0M; 4 not under a Rule 10b5-1 plan ($11.0M); 0 by opportunistic insiders, 0 by routine insiders (three-year test, Cohen, Malloy & Pomorski 2012).
- Analysts: Buy (mean 1.83 on a 1–5 scale) (6 analysts), mean target USD 49.5 (range 43–65).
- Total return with dividends: 1Y +29.6% vs S&P 500 +14.9%; 5Y +14.1% vs S&P 500 +80.3%.
- Next earnings: 2026-11-05, EPS estimate USD -0.51, revenue estimate $210M.

## Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $235M | $238M | $255M | $304M | $381M | $526M |
| Operating income | — | — | $57.9M | $68.7M | — | — |
| Net income | $126M | -$54.4M | -$21.1M | -$2.1M | -$70.8M | -$122M |
| EPS (diluted) | $37.92 | -$9.27 | -$3.85 | -$0.54 | -$4.22 | — |
| Free cash flow | -$39.2M | -$27.1M | -$7.3M | -$27.0M | -$8.9M | -$52.7M |
| Operating margin | — | — | 22.7% | 22.6% | — | — |
| Net margin | 53.5% | -22.8% | -8.3% | -0.7% | -18.6% | -23.3% |
| Revenue growth | -38.9% | +1.6% | +7.1% | +19.2% | +25.2% | — |
| Cash + short-term investments | $78.7M | $16.9M | $4.1M | $17.0M | $11.0M | — |
| Total debt | $683M | $671M | $629M | $651M | $690M | — |
Fiscal years end Dec. EPS is split-adjusted.

## Valuation (price ÷ last four quarters, through Jun 30, 2026)
P/S 3.1x · EV/Sales 6.0x · P/B 1.9x · FCF yield -3.24% · Earnings yield -7.52% · Net debt $1.52B · EV $3.15B

## Superinvestors (SEC 13F-HR, Q2 2026)
1 of 80 tracked investors hold SNDA. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| First Eagle Investment | First Eagle Investment Management | <0.01% | $2.3M | New position |

## Insider sales (SEC Form 4, open-market, last ~7 months)
0 of 4 under a Rule 10b5-1 trading plan (scheduled in advance). Unplanned sales were timed by the insider.
| Trade date | Insider | Role | Shares | Value | % of holdings sold | 10b5-1 plan | Insider type |
|---|---|---|---|---|---|---|---|
| 2026-08-28…2026-09-01 | Simanovsky Michael | Director | 123,988 | $4.8M | 1.8% | No | Too little history (no open-market trades in 2023) |
| 2026-08-25…2026-08-27 | Simanovsky Michael | Director | 145,086 | $5.9M | 2% | No | Too little history (no open-market trades in 2023) |
| 2026-08-14 | Harris Benjamin P | Director | 6,269 | $249K | 38.4% | No | Too little history (no open-market trades in 2023 or 2025) |
| 2026-05-13 | Harris Benjamin P | Director | 2,500 | $94K | 21.4% | No | Too little history (no open-market trades in 2023 or 2025) |
% of holdings sold = shares sold ÷ (shares sold + all holdings the insider reported on that Form 4, direct and through trusts).
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.

## Analysts
Consensus Buy (mean 1.83 on a 1–5 scale), 6 analysts; mean target USD 49.5 (low 43, high 65).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-09-04 | Baird | Upgrade | Neutral → Outperform | $37 → $43 |
| 2026-09-01 | Morgan Stanley | Target raised | Equal-Weight | $38 → $44 |
| 2026-08-11 | Cantor Fitzgerald | Target raised | Overweight | $42 → $47 |
| 2026-08-11 | Compass Point | Initiated | Buy | $65 |
| 2026-07-27 | Citizens | Initiated | Market Outperform | $50 |
| 2026-06-29 | RBC Capital | Target raised | Outperform | $45 → $48 |

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-23) | 5Y (from 2021-10-18) |
|---|---|---|
| Total return | +29.6% | +14.1% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +29.7% | +2.7% |
| Volatility (annualized) | 37.3% | 58.8% |
| Max drawdown | -22.3% (Jul 2026→Oct 2026) | -81.3% (Feb 2022→May 2023) |

## Peers (Medical Care Facilities)
CMPS (COMPASS Pathways Plc - American) USD 11.63 -1.77% · HCSG (Healthcare Services Group, Inc.) USD 24.79 +14.19% · ARDT (Ardent Health, Inc.) USD 12.36 +2.49% · AGL (agilon health, inc.) USD 90.29 -0.77% · PNTG (The Pennant Group, Inc.) USD 42.23 +2.90% · AMN (AMN Healthcare Services Inc) USD 46.82 +8.86%

## More
Full page: https://nexqual.com/SNDA · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt

## Revenue by product line (quarter ended 2026-06-30)

| Line | Revenue | Share | YoY |
|---|---|---|---|
| Resident revenue | $188.0M | 90.5% | +129.7% |
| — Housing and support services (part of Resident revenue) | $182.7M | 88.0% | +125.7% |
| — Ancillary services (part of Resident revenue) | $4.4M | 2.1% | +1226.2% |
| — Management fee income (part of Resident revenue) | $1.2M | 0.6% | +4.5% |
| Managed community reimbursement revenue | $10.9M | 5.3% | +3.7% |
| Rental income | $7.5M | 3.6% | — |
| Community fees | $966,000 | 0.5% | +65.7% |
| Total revenue | $207.6M | 100% | — |

## Company outlook (8-K filed 2026-08-10)

- "Historical cost accounting for real estate assets implicitly assumes that the value of real estate assets diminish predictably over time."
- "(2) Transaction, transition and restructuring costs relate to legal and professional fees incurred for transactions, restructuring projects, or related projects."
- "(2) Transaction, transition and restructuring costs relate to legal and professional fees incurred for transactions, restructuring projects, or related projects."

## Analyst estimates and revisions

| Period | EPS est. | 90d ago | Change | Revenue est. | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends 2026-09-30) | $-0.51 | $-0.22 | +129.5% | $210.1M | 2 |
| Next quarter (ends 2026-12-31) | $-0.47 | $-0.16 | +196.9% | $211.2M | 2 |
| Current fiscal year (ends 2026-12-31) | $-3.59 | $-2.97 | +20.9% | $741.5M | 4 |
| Next fiscal year (ends 2027-12-31) | $-1.65 | $-0.44 | +275.0% | $871.6M | 2 |